For people with diabetes, a retinal photograph has traditionally answered one major question: Is diabetic retinopathy developing? However, artificial intelligence is beginning to uncover much more. Emerging retinal AI models for systemic risk assessment can detect patterns associated with cardiovascular disease, kidney disease, blood pressure, and metabolic health. As a …
Read More »Beyond Coverage: How GLP‑1s, Tech, and AI Are Reshaping Diabetes Equity in 2026
What happens when breakthrough treatments only reach the few who can afford or access them? That’s the growing dilemma in diabetes care. As GLP‑1 medications, digital tools, and AI reshape how we treat this chronic disease, the risk is clear: innovation could deepen inequality if we don’t act intentionally. Equity …
Read More »AI Decision Support for CGM and Insulin: How to Use It Without Losing Clinical Judgment
AI decision support in diabetes care is reshaping how clinicians manage continuous glucose monitoring (CGM) and insulin dosing. These tools deliver quick data-driven recommendations, raising key questions: How do we preserve clinical judgment? Where does AI end and provider expertise begin? This article explains how to safely evaluate and use …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.